D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.76% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Motorcar Parts of America
MPAA
$264M
| $944K | ﹤0.01% |
101,122
+9,830
| +11% | +$82.9K |
|
|
EXAI
3027
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $944K | ﹤0.01% |
+147,225
| New | +$834K |
|
3028
Capitol Federal Financial
CFFN
$1.07B
| $942K | ﹤0.01% |
+146,058
| New | +$784K |
|
3029
Celldex Therapeutics
CLDX
$2.8B
| $942K | ﹤0.01% |
23,746
-13,038
| -35% | -$383K |
|
3030
HF Sinclair
DINO
$16.4B
| $940K | ﹤0.01% |
16,923
-29,999
| -64% | -$1.64M |
|
3031
SiriusPoint
SPNT
$3.01B
| $938K | ﹤0.01% |
80,900
| – | – |
|
3032
CALL
Vertiv
VRT
$110B
| $937K | ﹤0.01% |
+19,500
| New | +$830K |
|
3033
Planet Fitness
PLNT
$4.29B
| $934K | ﹤0.01% |
+12,792
| New | +$786K |
|
3034
Atomera
ATOM
$203M
| $928K | ﹤0.01% |
132,449
-16,767
| -11% | -$111K |
|
3035
CALL
Atlassian
TEAM
$24.3B
| $928K | ﹤0.01% |
3,900
-800
| -17% | -$157K |
|
|
MASI
3036
CALL
DELISTED
Masimo
MASI
| $926K | ﹤0.01% |
+7,900
| New | +$736K |
|
3037
United Microelectronic
UMC
$47.9B
| $926K | ﹤0.01% |
109,416
-834,251
| -88% | -$6.36M |
|
|
ZUO
3038
DELISTED
Zuora, Inc.
ZUO
| $925K | ﹤0.01% |
98,415
-125,367
| -56% | -$1.03M |
|
3039
MGE Energy Inc
MGEE
$3.08B
| $924K | ﹤0.01% |
+12,785
| New | +$925K |
|
|
ONIT
3040
Onity Group
ONIT
$336M
| $924K | ﹤0.01% |
30,023
-1,544
| -5% | -$39.5K |
|
|
SP
3041
DELISTED
SP Plus Corporation
SP
| $921K | ﹤0.01% |
17,972
-21,439
| -54% | -$1.08M |
|
3042
Molina Healthcare
MOH
$10.4B
| $921K | ﹤0.01% |
2,549
-3,160
| -55% | -$1.11M |
|
3043
eHealth
EHTH
$43.2M
| $921K | ﹤0.01% |
105,607
-12,879
| -11% | -$105K |
|
3044
Clearway Energy Class C
CWEN
$5B
| $920K | ﹤0.01% |
33,535
-141,547
| -81% | -$3.3M |
|
3045
Southside Bancshares
SBSI
$966M
| $920K | ﹤0.01% |
29,365
-12,807
| -30% | -$373K |
|
3046
MDU Resources
MDU
$4.37B
| $918K | ﹤0.01% |
83,705
+58,910
| +238% | +$622K |
|
3047
Algoma Steel Group Warrant
ASTLW
$160K
| $917K | ﹤0.01% |
506,391
+227,989
| +82% | +$268K |
|
|
TEN
3048
PUT
Tsakos Energy Navigation Ltd
TEN
$1.18B
| $913K | ﹤0.01% |
+41,100
| New | +$875K |
|
3049
Aldeyra Therapeutics
ALDX
$95.3M
| $913K | ﹤0.01% |
260,056
+214,089
| +466% | +$661K |
|
3050
PUT
iQIYI
IQ
$1.19B
| $913K | ﹤0.01% |
187,000
-40,000
| -18% | -$189K |
|
Similar funds
D.E. Shaw & Co's Q4 2023 Portfolio in Review
As of Q4 2023, D.E. Shaw & Co held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- D.E. Shaw & Co added most to Netflix in Q4 2023, an estimated $751M increase.
- D.E. Shaw & Co's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- D.E. Shaw & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- D.E. Shaw & Co opened 575 new positions and closed 527 in Q4 2023.
- D.E. Shaw & Co's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.